Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 19INDUSTRY 8OTHER_GOV 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Neoplasms 1Esophageal Neoplasms 1

Interventions

Capecitabine 28apatinib 25Oxaliplatin 24Cisplatin 24tislelizumab 23Gemcitabine 23Irinotecan 19Paclitaxel 18Carboplatin 18Docetaxel 15Bevacizumab 15Fluorouracil 14Drug Therapy 13Cyclophosphamide 11pembrolizumab 10camrelizumab 10Vinorelbine 9Radiation 9S 1 (combination) 8Leucovorin 8Cetuximab 8toripalimab 7sintilimab 7Rituximab 7Erlotinib Hydrochloride 7pyrotinib 6Gefitinib 6Albumin-Bound Paclitaxel 6fludarabine 5anlotinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER_GOV × CP protocol × Clear all
NCT02924909 2018-03-20

QUIMERA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
50 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00147680 2012-02-02

Uterine Papillary Serous Cancer (UPSC) Trial

Queensland Centre for Gynaecological Cancer

Phase 2 Completed
30 enrolled
Gynecologic

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡